Andrea Marzi
#91,836
Most Influential Person Now
German-American virologist
Andrea Marzi's AcademicInfluence.com Rankings
Andrea Marzibiology Degrees
Biology
#8772
World Rank
#11902
Historical Rank
Virology
#240
World Rank
#247
Historical Rank
Download Badge
Biology
Why Is Andrea Marzi Influential?
(Suggest an Edit or Addition)According to Wikipedia, Andrea Marzi is a German-American virologist. She is chief of the immunobiology and molecular virology unit at the Rocky Mountain Laboratories. Marzi investigates the pathogenesis of filoviruses and vaccine development. She received the in recognition of her research.
Andrea Marzi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses (2020) (2460)
- DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus (2004) (348)
- Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor (2004) (257)
- DC-SIGN and CLEC-2 Mediate Human Immunodeficiency Virus Type 1 Capture by Platelets (2006) (230)
- Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin (2009) (226)
- Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates (2013) (223)
- Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. (2011) (215)
- LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus (2005) (199)
- S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry into Hepatoma Cell Lines and Is Targeted by Neutralizing Antibodies in Infected Patients (2004) (188)
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain (2015) (188)
- Cellular p32 Recruits Cytomegalovirus Kinase pUL97 to Redistribute the Nuclear Lamina* (2005) (176)
- Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool (2016) (169)
- Ebola virus vaccines: an overview of current approaches (2014) (144)
- Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever (2012) (135)
- Highly Conserved Regions within the Spike Proteins of Human Coronaviruses 229E and NL63 Determine Recognition of Their Respective Cellular Receptors (2006) (118)
- K18-hACE2 mice develop respiratory disease resembling severe COVID-19. (2021) (110)
- Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine (2013) (108)
- A Novel Model of Lethal Hendra Virus Infection in African Green Monkeys and the Effectiveness of Ribavirin Treatment (2010) (98)
- Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. (2011) (97)
- Enzyme-Linked Immunosorbent Assay for Detection of Filovirus Species-Specific Antibodies (2010) (96)
- K18-hACE2 mice develop respiratory disease resembling severe COVID-19 (2020) (92)
- Pandemic Swine-Origin H1N1 Influenza A Virus Isolates Show Heterogeneous Virulence in Macaques (2010) (88)
- Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus. (2011) (88)
- The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials (2018) (88)
- The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo (2012) (86)
- Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus (2013) (84)
- Replication-Deficient Ebolavirus as a Vaccine Candidate (2009) (84)
- Immunobiology of Ebola and Lassa virus infections (2017) (83)
- Discovery of an antibody for pan-ebolavirus therapy (2016) (80)
- Analysis of the Interaction of Ebola Virus Glycoprotein with DC-SIGN (Dendritic Cell—Specific Intercellular Adhesion Molecule 3—Grabbing Nonintegrin) and Its Homologue DC-SIGNR (2007) (78)
- An Ebola whole-virus vaccine is protective in nonhuman primates (2015) (77)
- Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses (2015) (74)
- Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain (2015) (73)
- The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin (2011) (70)
- Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections. (2011) (69)
- Cathepsin B & L Are Not Required for Ebola Virus Replication (2012) (69)
- Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. (2014) (69)
- Vesicular Stomatitis Virus-Based Vaccine Protects Hamsters against Lethal Challenge with Andes Virus (2011) (66)
- Ebola and Marburg virus vaccines (2017) (64)
- Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona. (2016) (62)
- Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge. (2009) (61)
- Rhabdovirus-Based Vaccine Platforms against Henipaviruses (2014) (58)
- Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation. (2006) (58)
- Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus (2015) (57)
- Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection (2016) (57)
- Inhibition of Marburg Virus Budding by Nonneutralizing Antibodies to the Envelope Glycoprotein (2012) (56)
- The Signal Peptide of the Ebolavirus Glycoprotein Influences Interaction with the Cellular Lectins DC-SIGN and DC-SIGNR (2006) (56)
- A VSV-based Zika virus vaccine protects mice from lethal challenge (2018) (56)
- Lack of Protection Against Ebola Virus from Chloroquine in Mice and Hamsters (2015) (54)
- Ebola vaccine trials: progress in vaccine safety and immunogenicity (2019) (52)
- Inactivation of RNA Viruses by Gamma Irradiation: A Study on Mitigating Factors (2016) (52)
- Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages (2017) (52)
- Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection. (2011) (51)
- Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models. (2018) (51)
- Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus. (2011) (48)
- Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients. (2016) (47)
- Filoviruses: Ecology, Molecular Biology, and Evolution. (2018) (46)
- Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus (2015) (43)
- Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein. (2013) (39)
- Ebola: Lessons on Vaccine Development. (2018) (38)
- A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge (2018) (36)
- Ebola Virus: Pathogenesis and Countermeasure Development. (2019) (36)
- Amino Acid 324 in the Simian Immunodeficiency Virus SIVmac V3 Loop Can Confer CD4 Independence and Modulate the Interaction with CCR5 and Alternative Coreceptors (2004) (32)
- The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent (2016) (32)
- C-type lectins do not act as functional receptors for filovirus entry into cells. (2010) (31)
- Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation (2019) (31)
- Ebola virus vaccines – reality or fiction? (2016) (30)
- Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens (2006) (30)
- A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades (2020) (29)
- Marburg virus pathogenesis – differences and similarities in humans and animal models (2019) (29)
- α-Glutamyl-β-naphthylamide hydrolase of rabbit small intestine: Localization in the brush border and separation from other brush border peptidases (1976) (28)
- Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge (2019) (28)
- Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs (2015) (28)
- Ebola Virus Does Not Block Apoptotic Signaling Pathways (2013) (27)
- Complete Genome Sequences of Three Ebola Virus Isolates from the 2014 Outbreak in West Africa (2014) (26)
- Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization. (2006) (26)
- Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection (2019) (26)
- Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection (2017) (26)
- A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever (2016) (25)
- The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak (2016) (25)
- Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin. (2007) (23)
- Current Ebola Virus Vaccine Progress (2018) (23)
- Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015. (2016) (22)
- Next-Generation Sequencing Reveals a Controlled Immune Response to Zaire Ebola Virus Challenge in Cynomolgus Macaques Immunized with Vesicular Stomatitis Virus Expressing Zaire Ebola Virus Glycoprotein (VSVΔG/EBOVgp) (2015) (21)
- Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine (2021) (20)
- Mechanism of chlorpromazine prevention of carbon tetrachloride-induced liver necrosis. (1980) (20)
- Fcγ-receptor IIa-mediated Src Signaling Pathway Is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection (2016) (20)
- Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines. (2015) (20)
- The role of the alternative coreceptor GPR15 in SIV tropism for human cells. (2012) (19)
- Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model (2021) (18)
- Recently Emerged Swine Influenza A Virus (H2N3) Causes Severe Pneumonia in Cynomolgus Macaques (2012) (18)
- Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease (2021) (18)
- Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection (2022) (18)
- Niemann-Pick C1 Heterogeneity of Bat Cells Controls Filovirus Tropism. (2020) (18)
- Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out Mice (2018) (18)
- Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses. (2016) (18)
- Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure. (2013) (17)
- Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection. (2015) (16)
- Single-Nucleotide Polymorphisms in Human NPC1 Influence Filovirus Entry Into Cells. (2018) (15)
- Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. (2015) (14)
- Kyasanur Forest Disease and Alkhurma Hemorrhagic Fever Virus—Two Neglected Zoonotic Pathogens (2020) (13)
- Ebola Virus Infection in Commonly Used Laboratory Mouse Strains. (2018) (13)
- A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus (2018) (12)
- Pyrazole prevention of CC14-induced ultrastructural changes in rat liver. (1980) (12)
- A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades. (2020) (12)
- Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model (2021) (12)
- Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge. (2019) (12)
- Suspected Exposure to Filoviruses Among People Contacting Wildlife in Southwestern Uganda. (2018) (10)
- The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms (2020) (10)
- Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain Tumors (2020) (10)
- Critical reflections on intersubjectivity in psychoanalysis (2006) (10)
- A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection (2020) (9)
- Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine (2022) (9)
- Attachment Factor and Receptor Engagement of Sars Coronavirus and Human Coronavirus NL63 (2006) (9)
- Optimization of single dose VSV-based COVID-19 vaccination in hamsters (2021) (9)
- An updated Ebola vaccine: immunogenic, but will it protect? (2015) (8)
- Monoclonal Antibody Cocktail Protects Hamsters From Lethal Marburg Virus Infection. (2018) (8)
- Clinical Chemistry of Patients With Ebola in Monrovia, Liberia. (2016) (8)
- When the analyst is physically ill: Vicissitudes in the analytical relationship (2005) (8)
- VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern (2022) (8)
- Long-Range Polymerase Chain Reaction Method for Sequencing the Ebola Virus Genome From Ecological and Clinical Samples. (2018) (8)
- Novel neutralizing monoclonal antibodies protect rodents against lethal filovirus challenges (2014) (7)
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses (2020) (7)
- Chicken resistance to dimethylnitrosamine acute effects on the liver: a comparative study with other species. (1982) (7)
- Psychoanalysis, Identity, and the Internet (2016) (6)
- Enhancement of the dimethylnitrosamine acute effects in rat liver by prior treatment with triton WR-1339. (1981) (6)
- Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon (2021) (6)
- Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice (2021) (6)
- The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway (2021) (6)
- Closer than ever to an Ebola virus vaccine (2017) (5)
- Biodefence research two decades on: worth the investment? (2021) (5)
- Ebola Virus Glycoprotein Domains Associated with Protective Efficacy (2021) (5)
- Effects of cysteine and cystamine on the carbon tetrachloride induced decrease in arachidonic acid content of rat liver microsomal phospholipids. (1981) (5)
- Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters (2022) (5)
- An introduction to the Marburg virus vaccine consortium, MARVAC (2022) (5)
- Development of an Enzyme-Linked Immunosorbent Assay to Determine the Expression Dynamics of Ebola Virus Soluble Glycoprotein during Infection (2020) (5)
- Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques. (2018) (4)
- Evaluation of Ebola Virus Countermeasures in Guinea Pigs. (2017) (4)
- A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection. (2020) (3)
- Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses (2021) (3)
- Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins (2022) (3)
- Effect of ovarian hormones upon liver mitochondrial function in diabetic rats. (1988) (3)
- A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo. (2007) (3)
- Alpha-Glutamyl-beta-naphthylamide hydrolase of rabbit small intestine. Localization in the brush border and separation from other brush border peptidases. (1976) (2)
- Cyberghosts from the depths (2018) (2)
- Ebola virus vaccines: an overview of current (2014) (2)
- Favipiravir (T-705) Protects IFNAR−/− Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner (2021) (2)
- A platform technology for generating subunit vaccines against diverse viral pathogens (2022) (2)
- Studies on the prevention of CCl4 induced liver necrosis by agents having effects on cell membrane. (1980) (2)
- PEPTIDASE ACTIVITIES OF THE BRUSH BORDER OF RABBIT SMALL INTESTINAL MUCOSA (1974) (2)
- A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge (2018) (1)
- A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus (2021) (1)
- Development of a multiplex microsphere immunoassay for the detection of antibodies against highly pathogenic viruses in human and animal serum samples (2020) (1)
- Recombinant Ebolavirus antigens from insect cells are potent immunogens inducing cellular and humoral immunity in rodents and non-human primates and provide protection against virus challenge (P4325) (2013) (1)
- Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques (2023) (1)
- Promethazine administration to rats and CCl4 induced lipid peroxidation of liver microsomal lipids. (1980) (1)
- Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern (2021) (1)
- Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment (2021) (1)
- Alkhurma haemorrhagic fever virus causes lethal disease in IFNAR-/- mice (2021) (1)
- Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine (2018) (1)
- VSV-based vaccine provides species-specific protection against Sudan virus challenge in macaques (2022) (1)
- Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern (2022) (1)
- On: confidentiality with respect to third parties. (2005) (0)
- Vesicular Stomatitis Virus-Based Vaccine Protects Hamsters against Lethal Challenge with Andes Virus (cid:1) (2011) (0)
- Ebola and Marburg virus vaccines (2017) (0)
- Psychoanalysis, the Digital World, and the Pandemic: Frontiers and Challenges in Different Settings (2023) (0)
- Marburg virus pathogenesis – differences and similarities in humans and animal models (2019) (0)
- Effect in vivo of endogenous sexual hormones upon the liver mitochondrial function compared in male and female diabetic rats. (1989) (0)
- CD47 expression attenuates Ebola virus-induced immunopathology in mice. (2021) (0)
- Current Ebola Virus Vaccine Progress (2019) (0)
- Light and shadow in online analysis (2018) (0)
- A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus (2021) (0)
- The body vanishes?1 Preliminary thoughts on bodily experience and the identity of the analyst in remote analysis (2021) (0)
- Suspected exposure to filoviruses among people contacting wildlife in Southwestern Uganda (2019) (0)
- 189: Differences in cytokine responses during infection with high and low pathogenic Ebola viruses (2013) (0)
- Single-dose treatment with VSV-EBOV expressing Ebola virus-specific artificial miRNAs does not protect mice from lethal disease (2023) (0)
- VSV-EBOV Induces Temporal and Dose-Dependent Transcriptional Responses in Non-human Primates (2021) (0)
- Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine (2022) (0)
- Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model (2022) (0)
- Integrity of membrane fluidity and fatty acid environment are necessary for Ebola virus VP40 assembly and release of viral particles (2022) (0)
- A VSV-based Zika virus vaccine protects mice from lethal challenge (2018) (0)
- Hemorrhagic Fever Viruses: Pathogenesis and Countermeasures (2022) (0)
- Transcriptional Analysis of Infection With Early or Late Isolates From the 2013–2016 West Africa Ebola Virus Epidemic Does Not Suggest Attenuated Pathogenicity as a Result of Genetic Variation (2021) (0)
- Increased disease severity of Ebola virus infection with blockade of CD47 (2021) (0)
- [MADNESS, POETRY, TESTAMENT IN “LE LIBERE DONNE DI MAGLIANO” (THE FREE WOMEN OF MAGLIANO) BY MARIO TOBINO] (2018) (0)
- Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection (2017) (0)
- Establishing a Mouse Model for Sexual Transmission and Male Reproductive Tract Persistence of Ebola virus. (2023) (0)
- P014 Ebola virus induces a differential cytokine response and NFKB activation in infected cells (2012) (0)
- An Ebola virus vaccine that leverages helper T cells induced by prior BCG immunization (2020) (0)
- Instructions for use Title C-type lectins do not act as functional receptors for filovirusentry into cells (2017) (0)
This paper list is powered by the following services:
Other Resources About Andrea Marzi
What Schools Are Affiliated With Andrea Marzi?
Andrea Marzi is affiliated with the following schools:
